Evidence map›Paper›PMID 35734062›Full record

ArticleLaryngoscope investigative otolaryngology2022

Management of clinically node-negative glottic squamous cell carcinoma patients according to risk-scoring model for occult lymph node metastases.

Yu Heng, Chengzhi Xu, Hanqing Lin, Xiaoke Zhu, Liang Zhou, Ming Zhang, Chunping Wu, Lei Tao

Open access · goldAbstract read
In one paragraph

Article in Laryngoscope investigative otolaryngology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 4 citations in OpenAlex.

  1. Guideline
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Yu HengENT Institute and Department of Otorhinolaryngology, Eye & ENT Hospital Fudan University Shanghai China.ORCID https://orcid.org/0000-0001-5625-8324
Chengzhi XuENT Institute and Department of Otorhinolaryngology, Eye & ENT Hospital Fudan University Shanghai China.
Hanqing LinENT Institute and Department of Otorhinolaryngology, Eye & ENT Hospital Fudan University Shanghai China.ORCID https://orcid.org/0000-0003-3323-1828
Xiaoke ZhuENT Institute and Department of Otorhinolaryngology, Eye & ENT Hospital Fudan University Shanghai China.
Liang ZhouENT Institute and Department of Otorhinolaryngology, Eye & ENT Hospital Fudan University Shanghai China.
Ming ZhangENT Institute and Department of Otorhinolaryngology, Eye & ENT Hospital Fudan University Shanghai China.
Chunping WuENT Institute and Department of Otorhinolaryngology, Eye & ENT Hospital Fudan University Shanghai China.
Lei TaoENT Institute and Department of Otorhinolaryngology, Eye & ENT Hospital Fudan University Shanghai China.
Eye & ENT Hospital of Fudan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Glottic squamous cell carcinoma (GSCC) is the most prevalent type of laryngeal carcinoma. The value of prophylactic lymph node dissection (LND) in resected GSCC remains controversial. This study aims to quantitatively assess the probability of occult lymph node metastasis (LNM) for GSCC patients and devise individualized postoperative radiotherapy strategies. Methods: A total of 1319 patients with GSCC were retrospectively analyzed. Results: GSCC patients with T1-T2 stages showed significantly lower LNM rate than those with T3-T4 stages. For patients with T3-T4 GSCC, multivariate logistic analyses indicated that three factors-maximum tumor diameter (MTD) of more than 2.0 cm, relatively low differentiation, and tumor invasive depth of no less than 1.0 cm-were independent risk factors for the existence of LNM. A predictive nomogram was established based on these factors. The accuracy and validity of our model were verified by 0.716 and remained at 0.717 after 1000 bootstrapping. The calibration curve was also plotted and showed a favorable agreement. The patients were stratified into two groups based on their individual LNM risk points. Possible LNM rates for low-risk and high-risk subgroups were 4.7% and 25.2%, respectively. Conclusions: A new post-operative strategy selection flow chart was established based on our newly created nomogram which can effectively predict the individualized possibility of occult LNM for GSCC patients. For clinical T3-4N0 patients in the high-risk subgroup, prophylactic dose post-operative radiation therapy is recommended. However, for all those clinically diagnosed as T1-2N0 stage, regular follow-up is sufficient in view of the low occult LNM rate.Level of Evidence: 2a.

Indexed as

Glottic squamous cell carcinomaoccult contralateral lymph node metastasispostoperative adjuvant radiotherapyrisk prediction modeltreatment choice

Identifiers

PMID35734062
PMCPMC9195031
OpenAlexW4220850560

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.